(Q35050432)

6 August 2017

title

Emerging targets for the treatment of depressive disorder (English)

1 reference

6 August 2017

Karine AN Macritchie

1

1 reference

6 August 2017

Allan H Young

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Expert Opinion on Therapeutic Targets

6 August 2017

published in

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

601-612

1 reference

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Partial remission in depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Interferons, serotonin and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Trimipramine: a challenge to current concepts on antidepressives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Pharmacology of neural pathways affecting CRH secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Diurnal variation of mood and neuropsychological function in major depression with melancholia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

The chemical nature of the main central excitatory transmitter: a critical appraisal based upon release studies and synaptic vesicle localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Chronic effects of trimipramine, an antidepressant, on hippocampal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Long-term outcome of patients who receive ketamine during research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

A novel treatment of global cerebral ischaemia with a glycine partial agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Neurokinin(1) receptor antagonists as potential antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Reduced neuropeptide Y concentrations in suicide brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Smoking, smoking cessation, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Biological aspects of the link between smoking and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Presynaptic nicotinic ACh receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Distribution of nicotinic receptors in the human hippocampus and thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Effects of fluoxetine on wild and mutant neuronal alpha 7 nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Vagus nerve stimulation: a new tool for brain research and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.5.5.601

21 January 2018

Identifiers

DOI

10.1517/14728222.5.5.601

1 reference

6 August 2017

1 reference